Cover Image, Volume 20, Issue 11
Diabetes, Obesity and Metabolism,Volume 20, Issue 11, Page i-i, November 2018. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 8, 2018 Category: Endocrinology Authors: Sandro Spiller,
Matthias Bl üher,
Ralf Hoffmann Source Type: research
Diabetes, Obesity and Metabolism
,Volume 20, Issue 11, Page 2513-2514, November 2018. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 8, 2018 Category: Endocrinology Source Type: research
News and Views
Diabetes, Obesity and Metabolism,Volume 20, Issue 11, Page 2705-2707, November 2018. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 8, 2018 Category: Endocrinology Authors: Iskandar Idris Source Type: research
Glucagon ‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 8, 2018 Category: Endocrinology Authors: Dan Siskind,
Margaret Hahn,
Christoph U. Correll,
Anders Fink ‐Jensen,
Anthony W. Russell,
Nikolaj Bak,
Brian V. Broberg,
Julie Larsen,
Pelle L. Ishøy,
Tina Vilsbøll,
Filip K. Knop,
Steve Kisely,
Bjørn H. Ebdrup Source Type: research
Efficacy of intermittent empagliflozin supplementation on dietary self ‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 5, 2018 Category: Endocrinology Authors: Fukumi Yoshikawa,
Naoki Kumashiro,
Fumika Shigiyama,
Hiroshi Uchino,
Yasuyo Ando,
Hiroshi Yoshino,
Masahiko Miyagi,
Kayoko Ikehara,
Takahisa Hirose Source Type: research
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 4, 2018 Category: Endocrinology Authors: Stephen C. Bain,
Ofri Mosenzon,
Rosario Arechavaleta,
Pawel Bogda ński,
Abdurrahman Comlekci,
Agostino Consoli,
Chaicharn Deerochanawong,
Kathleen Dungan,
Maria C. Faingold,
Michael E. Farkouh,
Denise R. Franco,
Jeppe Gram,
Cristian Guja,
Pa Source Type: research
Personalized risk ‐based screening for diabetic retinopathy: a multivariate approach vs. the use of stratification rules
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 4, 2018 Category: Endocrinology Authors: Marta Garc ía‐Fiñana,
David M Hughes,
Christopher P Cheyne,
Deborah M Broadbent,
Amu Wang,
Arnošt Komárek,
Irene M Stratton,
Mehrdad Mobayen‐Rahni,
Ayesh Alshukri,
Jiten P Vora,
Simon P Harding Source Type: research
Effectiveness of high intensity interval training combined with resistance training vs. continuous moderate intensity training combined with resistance training in patients with type 2 diabetes – 1 year randomized controlled trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 4, 2018 Category: Endocrinology Authors: Jo ão P. Magalhães,
Pedro B. Júdice,
Rogério Ribeiro,
Rita Andrade,
João Raposo,
Hélder Dores,
Manuel Bicho,
Luís B. Sardinha Source Type: research
Should sodium ‐glucose co‐transporter‐2 inhibitors be considered as first‐line oral therapy for people with type 2 diabetes?
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 4, 2018 Category: Endocrinology Authors: Kamlesh Khunti,
Samuel Seidu,
Melanie J. Davies Source Type: research
Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 3, 2018 Category: Endocrinology Authors: Ian Pearce,
Rafael Sim ó,
Monica Lövestam‐Adrian,
David T. Wong,
Marc Evans Source Type: research
Effect of selenium supplementation on changes in glycated haemoglobin (HbA1c): Results from a multiple ‐dose, randomized controlled trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 3, 2018 Category: Endocrinology Authors: Saverio Stranges,
Margaret P. Rayman,
Kristian Hillert Winther,
Eliseo Guallar,
S øren Cold,
Roberto Pastor‐Barriuso Source Type: research
A post ‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 3, 2018 Category: Endocrinology Authors: Geremia B. Bolli,
Carol Wysham,
Miles Fisher,
Soazig Chevalier,
Anna M. G. Cali,
Bruno Leroy,
Matthew C. Riddle Source Type: research
Evaluation of the effects of dapagliflozin, a sodium ‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 2, 2018 Category: Endocrinology Authors: Masanori Shimizu,
Kunihiro Suzuki,
Kanako Kato,
Teruo Jojima,
Toshie Iijima,
Toshimitsu Murohisa,
Makoto Iijima,
Hidehiro Takekawa,
Isao Usui,
Hideyuki Hiraishi,
Yoshimasa Aso Source Type: research
Comment on: “Glucagon‐like peptide‐1 receptor expression in the human eye”
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 2, 2018 Category: Endocrinology Authors: Rafael Sim ó,
Cristina Hernández Source Type: research
Metformin is the key factor in elevated plasma growth differentiation factor ‐15 levels in type 2 diabetes: A nested, case–control study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 2, 2018 Category: Endocrinology Authors: Andrea Natali,
Lorenzo Nesti,
Elena Venturi,
Angela C. Shore,
Faisel Khan,
Kim Gooding,
Phillip E. Gates,
Helen C. Looker,
Fiona Dove,
Isabel Goncalves,
Margaretha Persson,
Jan Nilsson,
on behalf of the SUMMIT consortium Source Type: research
